Literature DB >> 8918917

A specific RNA structural motif mediates high affinity binding by the HIV-1 nucleocapsid protein (NCp7).

P Allen1, B Collins, D Brown, Z Hostomsky, L Gold.   

Abstract

Current research indicates that the nucleocapsid protein (NCp7) of human immunodeficiency virus type 1 (HIV-1) interacts with a variety of RNA substrates during the progression of the viral life cycle. The RNA features specifically recognized by the protein, however, have yet to be identified. SELEX was used to generate a set of RNAs whose affinities for nucleocapsid were on the order of 2 x 10(-9) M. Comparative analysis revealed that each RNA contains a highly conserved fourteen nucleotide sequence-block. Computer modeling and structure probing experiments indicate that the RNA ligands use the consensus sequence to fold into hairpins with an identical asymmetric bulge. The presence of the nucleocapsid protein protects the asymmetric bulge from ribonuclease attack, suggesting that it is the key element in protein recognition. A search for similar structural motifs within the HIV genome reveals several potential interaction sites for the nucleocapsid protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8918917     DOI: 10.1006/viro.1996.0605

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site.

Authors:  Y X Feng; S Campbell; D Harvin; B Ehresmann; C Ehresmann; A Rein
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  RNA binding properties of bunyamwera virus nucleocapsid protein and selective binding to an element in the 5' terminus of the negative-sense S segment.

Authors:  J C Osborne; R M Elliott
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  A heterologous, high-affinity RNA ligand for human immunodeficiency virus Gag protein has RNA packaging activity.

Authors:  J L Clever; R A Taplitz; M A Lochrie; B Polisky; T G Parslow
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides.

Authors:  R J Fisher; A Rein; M Fivash; M A Urbaneja; J R Casas-Finet; M Medaglia; L E Henderson
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Characterization of Rous sarcoma virus Gag particles assembled in vitro.

Authors:  F Yu; S M Joshi; Y M Ma; R L Kingston; M N Simon; V M Vogt
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  The gag domains required for avian retroviral RNA encapsidation determined by using two independent assays.

Authors:  E g Lee; A Yeo; B Kraemer; M Wickens; M L Linial
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection.

Authors:  P Purohit; S Dupont; M Stevenson; M R Green
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

8.  Potential inhibition of HIV-1 encapsidation by oligoribonucleotide-dendrimer nanoparticle complexes.

Authors:  Raveen Parboosing; Louis Chonco; Francisco Javier de la Mata; Thavendran Govender; Glenn Em Maguire; Hendrik G Kruger
Journal:  Int J Nanomedicine       Date:  2017-01-04

Review 9.  Monitoring Intact Viruses Using Aptamers.

Authors:  Penmetcha K R Kumar
Journal:  Biosensors (Basel)       Date:  2016-08-04

Review 10.  Artificially Expanded Genetic Information Systems for New Aptamer Technologies.

Authors:  Elisa Biondi; Steven A Benner
Journal:  Biomedicines       Date:  2018-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.